-- Enbridge, Helix BioPharma, Primaris May Move: Canada Equity Market Preview
-- Kelly Bit
-- 2010-08-06T21:18:18Z
-- http://www.bloomberg.com/news/2010-08-06/enbridge-helix-biopharma-primaris-canadian-equity-preview-for-aug-9.html

          
          
             Shares of the following companies may
have unusual moves in  Canadian trading  on Aug. 9.  
 Enbridge Inc.  (ENB CT): The carrier of most of the oil
imported to the U.S. from Canada said it may run the 6B pipeline
at lower pressure, once it’s restarted, until an investigation
of an oil spill in Michigan is completed. The company also said
it expanded the crude slate used to fill its Alberta Clipper
pipeline to include Western Canada Select, a heavy, high-sulfur
oil. The line fill is expected to be completed by the end of
September, spokeswoman Gina Jordan said.  
 Helix BioPharma Corp.  (HBP CT): The biotechnology company
completed a private placement of 4.53 million units at C$2.43
per unit, according to a statement on PRNewswire. The shares
closed at C$2.39 on Aug. 6. Polish investor Zbigniew Lobacz said
he bought the units, boosting his stake to 18 percent, including
common shares and warrants, according to a Marketwire press
release.  
 Primaris Retail Real Estate Investment Trust  (PMZ-U CT):
The owner of 28 shopping centers in Canada was cut to “market
perform” from “outperform” at Bank of Montreal.  
 To contact the reporters on this story:
 Kelly Bit  in New York at   kbit@bloomberg.net   
          
          


  


        